NCT03343847View on ClinicalTrials.gov

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.

PHASE3WithdrawnINTERVENTIONAL

Timeline

Start Date

January 27, 2018

Primary Completion Date

July 17, 2021

Study Completion Date

July 17, 2021

Conditions

Chemotherapy-induced Thrombocytopenia

Interventions

BIOLOGICAL

Romiplostim

This trial is designed to study romiplostim for the treatment of chemotherapy-induced thrombocytopenia (CIT) in patients receiving chemotherapy for the treatment of lymphoma.

OTHER

Placebo

Placebo Comparator